Skip to content
Screener

Stoke Therapeutics, Inc. STOK Short-Term Investments

Short-Term Investments at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$1.14B-14.5%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
$811.16M+130%
Praxis Precision Medicines, Inc. logo
Praxis Precision Medicines, Inc.PRAX
$283.79M+97.3%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$51.52M+187%
Septerna, Inc. logo
Septerna, Inc.SEPN
$275.8M+119%
Oric Pharmaceuticals, Inc. logo
Oric Pharmaceuticals, Inc.ORIC
$225.54M+46.1%

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$2.06B+187%
Enterprise value$1.91B+206%
P/S64.2×+60.6×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0×0.0×
Current ratio9×+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.

The source filing: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:06 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211874
Line itemMarch 31, 2026December 31, 2025
Assets
Current assets:
Cash and cash equivalents$155,659$84,220
Marketable securities - current187,886200,450
Accounts receivable4,4515,936
Prepaid expenses10,1158,736
Interest receivable1,6901,969
Other current assets6,8804,389

Item 1. Financial Statements.

FAQ

What is Stoke Therapeutics, Inc.'s short-term investments?
Stoke Therapeutics, Inc. (STOK) reported short-term investments of $187.89M in Q1 2026.
How has Stoke Therapeutics, Inc.'s short-term investments changed year-over-year?
Stoke Therapeutics, Inc.'s short-term investments increased by 127.7% year-over-year, from $82.51M to $187.89M.
What does short-term investments mean?
Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.

Ask your AI about Stoke Therapeutics, Inc.'s short-term investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude